Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Price Negotiation Pioneers: The Unique Position Of Imbruvica

Imbruvica — • Source: Shutterstock

Related Content

Patent Cliff Likely Accelerated By Two Years For Most Drugs On Medicare Price Negotiation List

Aug 30 2023

Big Rebates Already A Big Factor For Drugs On Medicare Negotiation List

Aug 29 2023

Medicare’s ‘Aduhelm’ Policy A Precedent For Accelerated Approvals But Not Cancer Drugs – Gottlieb

Aug 01 2023

Medicare Negotiation List Surprises Highlight The Importance Of Current Spending Data

Aug 30 2023

Related Companies

AbbVie Inc.

Johnson & Johnson

Janssen Pharmaceuticals Inc.

Astellas Pharma US Inc.

Pfizer Inc.

AstraZeneca PLC

Merck & Co., Inc.

Additional Topics

United States Pricing Debate Reimbursement Policy Cancer BioPharmaceutical

More from Medicare

More from Government Payers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window